Skip to main content
Premium Trial:

Request an Annual Quote

CytRx Faces Nasdaq Delisting Hearing

NEW YORK, April 28 (GenomeWeb News) - CytRx faces a May 13 hearing before the Nasdaq Qualifications Panel over a possible delisting of the company's common stock from the Nasdaq Small Cap market.

 

Los Angeles-based CytRx failed to file a Form 10-K annual report for 2003 and is working with an accounting firm to complete an audit of its 2003 financial statements with plans to file the form "as expeditiously as possible," the company said in a statement yesterday.

 

Additionally, the company said that Araios, its Worcester, Mass.-based subsidiary, will change its name to CytRx Laboratories.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.